| 2023-08-23 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 223 0.0002% | $844.00 | $188,212 | +7.78% | |
| 2023-03-28 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 1,007 0.0009% | $823.47 | $829,233 | -0.58% | |
| 2023-03-27 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 183 0.0002% | $821.70 | $150,372 | +0.21% | |
| 2023-02-06 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 752 0.0007% | $788.88 | $593,238 | +2.59% | |
| 2023-02-03 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 739 0.0007% | $764.50 | $564,966 | +2.25% | |
| 2022-12-02 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 610 0.0006% | $756.66 | $461,564 | +0.66% | |
| 2022-11-01 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 482 0.0004% | $758.06 | $365,386 | -0.27% | |
| 2022-10-17 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 358 0.0003% | $739.50 | $264,741 | +2.17% | |
| 2022-04-07 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 32 <0.0001% | $743.71 | $23,799 | -0.24% | |
| 2022-03-31 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 15 <0.0001% | $701.98 | $10,530 | +2.46% | |
| 2022-03-28 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 147 0.0001% | $694.94 | $102,156 | +2.96% | |
| 2022-03-21 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 300 0.0003% | $693.00 | $207,900 | +2.41% | |
| 2022-03-16 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 83 <0.0001% | $686.00 | $56,938 | +4.48% | |
| 2021-12-13 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 116 0.0001% | $662.50 | $76,850 | -2.99% | |
| 2021-12-10 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 781 0.0007% | $666.42 | $520,477 | -4.5% | |
| 2021-11-17 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 681 0.0006% | $645.08 | $439,299 | -1.04% | |
| 2021-08-10 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 537 0.0005% | $611.90 | $328,593 | +1.9% | |
| 2021-08-09 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 364 0.0003% | $617.83 | $224,891 | +2.02% | |
| 2020-08-04 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 696 0.0007% | $654.46 | $455,504 | -20.19% | |
| 2020-07-21 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Finance CFO | 391 0.0004% | $647.58 | $253,204 | -18.99% |